Correlation Between Cybin and Seelos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cybin and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cybin and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cybin Inc and Seelos Therapeutics, you can compare the effects of market volatilities on Cybin and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cybin with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cybin and Seelos Therapeutics.

Diversification Opportunities for Cybin and Seelos Therapeutics

-0.67

Correlation Coefficient

Cybin  Seelos Therapeutics

Excellent diversification

The 3 months correlation between Cybin and Seelos is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Cybin Inc and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and Cybin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cybin Inc are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of Cybin i.e., Cybin and Seelos Therapeutics go up and down completely randomly.

Pair Corralation between Cybin and Seelos Therapeutics

Given the investment horizon of 90 days Cybin Inc is expected to generate 0.38 times more return on investment than Seelos Therapeutics. However, Cybin Inc is 2.65 times less risky than Seelos Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.6 per unit of risk. If you would invest  1,200  in Cybin Inc on September 12, 2024 and sell it today you would lose (172.00) from holding Cybin Inc or give up 14.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	31.82%
Values	Daily Returns

Cybin Inc  vs.  Seelos Therapeutics

Cybin Inc

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cybin Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental drivers, Cybin displayed solid returns over the last few months and may actually be approaching a breakup point.

Seelos Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Seelos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Cybin and Seelos Therapeutics

The main advantage of trading using opposite Cybin and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cybin position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.

The idea behind Cybin Inc and Seelos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.